OUR JOURNEY

From Foundation
to Nationwide Reach.

Two decades of growth — from a regulatory-first import license to a nationwide healthcare platform.

Built through
purpose and
progress.

IP Biotech's journey is defined by a commitment to making essential vaccines and pharmaceutical products more accessible across the Philippines.

From establishing a strong regulatory foundation to expanding partnerships, public health programs, and healthcare reach, each chapter has strengthened our role in the country's life sciences landscape.

A journey shaped
by progress.

Each chapter represents a step in IP Biotech's development — from regulatory foundations and public health partnerships to portfolio growth and a new stage of leadership.

2009

Foundation & Strategic Partnership

Founded as a Filipino-owned biopharmaceutical firm; licensed by the Philippine FDA as a pharmaceutical importer and wholesaler.

2009
2010–2015

Building the Foundation

Expanded distribution capabilities and established key partnerships to support vaccine availability across the Philippines.

2010–2015
2016–2019

Network Expansion

Grew the Family Vaccine and Specialty Clinics (FVSC) network to serve more communities nationwide.

2016–2019
2020–2022

Pandemic Response

Supported national immunization efforts and expanded access to critical vaccines during the COVID-19 pandemic.

2020–2022
2023–Present

Continued Growth

Continued expansion of the FVSC network and portfolio to protect more Filipino families.

2023–Present
LOOKING AHEAD

Continuing the journey
toward greater access.

As IP Biotech moves forward, the focus remains on building strong partnerships, expanding healthcare reach, and helping make essential vaccines and pharmaceutical products accessible to more communities.

2009 Founded
26 FVSC Clinics
13 Provinces Reached
54K+ Patient Visits / Year

Meet the people
shaping our next chapter.

Meet Our Leadership